Ellie Reynolds, Manager of Regulatory Affairs at Proxima Clinical Research, is here to help growing MedTech companies learn more about Informational Meetings, a type of FDA Q-Submission that can be beneficial early on in your device's approval process.

Getting your device successfully approved while maintaining strict regulatory compliance across global markets is a big challenge.

As a clinical research organization (CRO), Proxima organizes its team into two distinct areas: early-stage advisory consulting and all-inclusive clinical trial services. We are well-versed in regulatory compliance consulting with the FDA for emerging medical devices and products.

The service you need, the speed you want, and the attention you deserve, Proxima works with emerging biotech and medical device companies across all phases of development.

‍